These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10222693)

  • 1. [Nausea is a common symptom in palliative care. Choice of treatment is based on the cause].
    Strang P; Jakobsson M
    Lakartidningen; 1999 Apr; 96(14):1743-5. PubMed ID: 10222693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding nausea and vomiting in advanced cancer.
    Perdue C
    Nurs Times; 2005 Jan 25-31; 101(4):32-5. PubMed ID: 15719789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Symptomatic alleviation of gastrointestinal symptoms].
    Baekke J; Meisner S; Bentsen HH
    Ugeskr Laeger; 2007 Oct; 169(44):3759-62. PubMed ID: 18028844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Managing nausea and vomiting in thoracic oncology].
    Le Moulec S; Vedrine L
    Rev Pneumol Clin; 2008 Apr; 64(2):76-80. PubMed ID: 18589287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nausea, vomiting and constipation in palliative care].
    Jordhøy MS; Aass N; Svensen R; Ervik B; Mohr W
    Tidsskr Nor Laegeforen; 2006 Feb; 126(5):620-3. PubMed ID: 16505875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention and therapy of nausea and vomiting caused by antineoplastic agents].
    Gao YL; Zheng S
    Zhonghua Fu Chan Ke Za Zhi; 1987 Jan; 22(1):51-3. PubMed ID: 3297548
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial.
    Mystakidou K; Tsilika E; Kalaidopoulou O; Chondros K; Georgaki S; Papadimitriou L
    Anticancer Res; 2002; 22(2B):1187-92. PubMed ID: 12168923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Consultative palliative care for nausea and vomiting in the home setting].
    van Heest FB; Meyboom-de Jong B; Otter R
    Ned Tijdschr Geneeskd; 2003 Jul; 147(27):1297-300. PubMed ID: 12868155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide in the management of bowel obstruction in terminal ovarian cancer.
    Mangili G; Franchi M; Mariani A; Zanaboni F; Rabaiotti E; Frigerio L; Bolis PF; Ferrari A
    Gynecol Oncol; 1996 Jun; 61(3):345-8. PubMed ID: 8641613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptom control in advanced gastrointestinal cancer.
    Baines MJ
    Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):375-9. PubMed ID: 10783988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction.
    Shima Y; Ohtsu A; Shirao K; Sasaki Y
    Jpn J Clin Oncol; 2008 May; 38(5):354-9. PubMed ID: 18490369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of gastrointestinal and respiratory symptoms in palliative care.
    Bade PF
    S D Med; 2008; Spec No.():47-9, 51-3. PubMed ID: 18642620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of common symptoms in terminally ill patients: Part I. Fatigue, anorexia, cachexia, nausea and vomiting.
    Ross DD; Alexander CS
    Am Fam Physician; 2001 Sep; 64(5):807-14. PubMed ID: 11563572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common gastrointestinal symptoms in pediatric palliative care: nausea, vomiting, constipation, anorexia, cachexia.
    Santucci G; Mack JW
    Pediatr Clin North Am; 2007 Oct; 54(5):673-89, x. PubMed ID: 17933617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of nausea nad vomiting in palliative medicine].
    Bausewein C
    Z Arztl Fortbild Qualitatssich; 2000 Sep; 94(7):569-73. PubMed ID: 11048341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliating patients who have unresectable colorectal cancer: creating the right framework and salient symptom management.
    Dunn GP
    Surg Clin North Am; 2006 Aug; 86(4):1065-92. PubMed ID: 16905424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptom control in advanced cancer.
    Storey P
    Semin Oncol; 1994 Dec; 21(6):748-53. PubMed ID: 7992090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and choices: an audit of the management of nausea, vomiting and bowel obstruction in metastatic ovarian cancer.
    Walker J; Lane P
    Contemp Nurse; 2007 Dec; 27(1):39-46. PubMed ID: 18386953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of intractable nausea and vomiting in patients at the end of life: "I was feeling nauseous all of the time . . . nothing was working".
    Wood GJ; Shega JW; Lynch B; Von Roenn JH
    JAMA; 2007 Sep; 298(10):1196-207. PubMed ID: 17848654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Management of Nausea and Vomiting Not Related to Anticancer Therapy in Patients with Cancer.
    Hardy J; Davis MP
    Curr Treat Options Oncol; 2021 Jan; 22(2):17. PubMed ID: 33443705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.